Some commercial preparations of Escherichia coli bacterial endotoxin lipopolysaccaride (LPS) are contaminated with biologically active substances.
Hardy
K W
KW
Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
White
T D
TD
D000241:Adenosine; D000818:Animals; D003956:Dialysis; D004340:Drug Contamination; D004926:Escherichia coli / Q000737:chemistry*; D018698:Glutamic Acid; D008070:Lipopolysaccharides / Q000494:pharmacology / Q000592:standards*; D015213:Neuroimmunomodulation / Q000187:drug effects; D009638:Norepinephrine / Q000493:pharmacokinetics; D010296:Parietal Lobe / Q000187:drug effects / Q000276:immunology; D051381:Rats; D013566:Sympathomimetics / Q000493:pharmacokinetics; D014316:Tritium
D008070:Lipopolysaccharides; D013566:Sympathomimetics; D014316:Tritium; D018698:Glutamic Acid; D000241:Adenosine; D009638:Norepinephrine